Fulcrum Therapeutics

#BreakingNews. Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD). “Sanofi is a proven leader in developing therapeutics for rare neuromuscular diseases and is the ideal partner to maximize the opportunity and reach of losmapimod outside the U.S.,” said Alex C. Sapir, Fulcrum’s president and chief executive officer. “This deal aligns with our core strategy, allowing Fulcrum to remain focused on preparations for commercialization of losmapimod in the U.S., while leveraging Sanofi’s exceptional global commercial capabilities and established infrastructure in key markets around the world. We are excited about the potential to provide the first approved treatment for FSHD patients, and we look forward to working with Sanofi to bring losmapimod to patients globally.” Learn more from our press release: https://ow.ly/I4jQ50REel8 #FSHD #FSHDawareness #Biotech #FulcrumTherapeutics #healthinnovations #newsalert

July 26 is National Disability Independence Day, bringing awareness to the barriers that people with disabilities face every day and celebrating the anniversary of the Americans with Disabilities Act (ADA). As a company focused on improving the lives of patients with rare diseases in areas of high unmet medical need, we at Fulcrum are all too aware that most people living with a rare disease are also living with disability. So today, we are proud to support the ADA 34th Anniversary. The ADA works to ensure all people with disabilities have the same rights and opportunities as everyone else. #ADA34

We recently celebrated 8 amazing years at Fulcrum Therapeutics! We are excited for another great year of progress in developing small molecules to improve the lives of patients with genetically defined rare diseases. #Anniversary #WeAreRare

Discover why working in a rare disease organization is so fulfilling for those on our team, including Pam. Learn about her passion and the critical impact of our mission at Fulcrum. #WeAreRare #Culture

We are incredibly proud to celebrate our FULcrew member, Adi Eldar-Lissai, PhD, on her appointment to the Board of Advisors at the Museum of Science in Boston. Her achievement exemplifies our dedication to science and its vital role in our company. Congratulations, Adi! #FULcrew #WeAreRare #Biotech

The last few weeks have been full of incredible events with our colleagues in the SCD community. Here are a few of the highlights: We had a blast at the World Sickle Cell Day Awareness Concert and Juneteenth Pop-Up hosted by SCDAA Miami-Dade County Chapter in Miami. It was a day of celebrating and raising awareness for the sickle cell disease community. Learn more about SCDAA Miami https://lnkd.in/eBq4sczT Pictured: Naomie Pigatt SCDAA, Miami Dade County, and Danielle Branch, MBA We were honored to join SCD visionary Dr. Tabatha McGee for the grand opening of Georgia’s first Sickle Cell Sanctuary. Much needed services at this wellness center will be provided free of charge to the SCD community. Learn more: https://lnkd.in/e-cm_kMv Pictured: Dr. Tabatha McGee, Executive Director of the Sickle Cell Foundation of Georgia, Inc. (SCFG), Christy M. Copeland, Fulcrum, and Danielle Branch, Fulcrum We were thrilled to attend the As One Foundation’s Houston Sickle Cell Therapeutics Summit & Health Fair. It was great to come together to support those living with the Sickle Cell Trait or Sickle Cell Disease. Pictured: Lakiea Bailey, Ph.D., Executive Director Sickle Cell Consortium and Mel Hayes Candice's Sickle Cell Fund Scholarship is an event dedicated to raising awareness of sickle cell disease within Afro-American, Latino, Caribbean, and Mediterranean communities. Their mission includes hosting annual events to raise funds, granting scholarships to students with Sickle Cell Disease, supporting vital research, and organizing community-based initiatives to benefit those living with SCD. Learn more about CSF: https://lnkd.in/epxq_rmn Pictured: Danielle Branch and Candice Deler, Founder and President of Candice’s Sickle Cell Fund (CSCF) 18th Annual Sickle Cell Disease Research and Educational Symposium William Engelman, MD of Fulcrum, presented at the 18th Annual Sickle Cell Disease Research and Educational Symposium. Dr. Engelman was introduced by Dr. Sheneil Alan, who chaired the session. The Symposium brought together over 500 leading researchers, physicians, clinicians, stakeholders, advocates, and social workers—all focused on finding better treatments and, ultimately, a cure for sickle cell disease. Pictured left to right: Lata Tricia Gooljarsingh, Christy Copeland,  Dr. William Engelman Inaugural Kevin J. Francis Scholarship & Awards Luncheon It was an honor to attend the Inaugural Kevin J. Francis Scholarship & Awards Luncheon hosted by A.S.A.P. Advancing Sickle Cell Project. The event celebrated achievements and awarded scholarships to support college completion and talent development for deserving sickle cell warriors and caregivers. Pictured: Tricia Gooljarsingh, Dr. Ofelia Alvarez, and Kemba Olabisi Gosier

A massive shoutout to Improv Asylum for an incredible session at our All Hands meeting! We learned innovative ways to build trust, communicate effectively, and sharpen our listening skills—all while having an absolute blast as a team. Thank you for the unforgettable experience! #FULcrew #WeAreRare

Looking for a career where you can leave an impact? Join our team! We’re hiring for the following positions: - Executive Director/Sr Director, Alliance Management - Senior Manager, Administrative Services - Vice President, Hematology Clinical Development Apply now at fulcrumtx.com/careers. #biotech #careers #WeAreRare

Happy Fourth of July from the FULcrew! 🇺🇸 Wishing you a safe and relaxing holiday. #FourthOfJuly #IndependenceDay #FULcrew

We've been thrilled to welcome some fantastic new team members to the FULcrew in 2024. Together, we're excited to make a meaningful impact! #careers #biotech